<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21873">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02121912</url>
  </required_header>
  <id_info>
    <org_study_id>CIA-89</org_study_id>
    <nct_id>NCT02121912</nct_id>
  </id_info>
  <brief_title>Laboratory Assessment of Pilairo Q CPAP Mask Performance and Ease of Use.</brief_title>
  <official_title>Pilairo Q In-lab Market Research - Europe</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants will undergo a normal sleep study. They will be randomised to use either a FPH
      Pilairo Q nasal pillow CPAP mask, or another mask. The sleep technician will record leak and
      pressure data, and complete questionnaires regarding satisfaction and ease of use at the end
      of the night. It is hypothesised that the Pilairo Q mask will be superior to other standard
      masks for CPAP therapy in terms of ease of use, satisfaction and overall titration
      experience.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be recruited from patients who visit the sleep lab for CPAP titration.
      Only eligible participants, that provide written informed consent, will be enrolled into the
      investigation

      Only those participants whom are previously diagnosed with an AHI &gt;5 can be approached and
      enrolled into the study.

      Once the consent form has been signed, participants will be randomly assigned to receive
      either Pilairo or any other standard care nasal/nasal pillows mask for their CPAP titration.
      A randomisation log will be provided by FPH.

      The titration session will take place as per the lab's routine practice.

      Throughout the night the Sleep Technician will record in the CRF the absolute leak value for
      the mask every 10 minutes.

      At the end of the session the Sleep Technician will complete a questionnaire in relation to
      the titration experience for that participant/mask. The data will be collected in the CRF
      that FPH staff will provide to the site.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Subjective questionnaires of satisfaction and ease of use.</measure>
    <time_frame>8 hours.</time_frame>
    <safety_issue>No</safety_issue>
    <description>The questionnaire is completed once at the end of the sleep study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mask leak</measure>
    <time_frame>Every 10min, for up to 8 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Sleep Technologist will record mask leak every 10minutes, over an 8 hour period during the sleep study.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>FPH Pilairo Q CPAP mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Sleep Technician will fit the FPH Pilairo Q CPAP mask to the participant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Any other market released nasal or nasal-pillow CPAP mask</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Sleep Technologist will fit the participant with any market released nasal or nasal-pillow CPAP mask</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FPH Pilairo Q CPAP mask</intervention_name>
    <description>CPAP nasal-pillow mask</description>
    <arm_group_label>FPH Pilairo Q CPAP mask</arm_group_label>
    <other_name>FPH Pilairo CPAP mask</other_name>
    <other_name>Pilairo Q</other_name>
    <other_name>Pilairo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Any other market released nasal or nasal-pillow CPAP mask</intervention_name>
    <description>Any other market released nasal or nasal-pillow CPAP mask</description>
    <arm_group_label>Any other market released nasal or nasal-pillow CPAP mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AHI equal or greater than 15 from the diagnostic night.

          -  Equal or greater than 18 years of age

        Exclusion Criteria:

          -  Inability to give informed consent.

          -  History of intolerance to CPAP.

          -  Anatomical or physiological conditions making CPAP therapy appropriate (for example a
             deviated septum)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martina Neddermann, Dr.med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Evangelisches Krankenhaus Herne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Annika Machleit-Ebner, MBA</last_name>
    <phone>+49232349892249</phone>
    <email>a.machleit@evk-herne.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Herne</name>
      <address>
        <city>Herne</city>
        <zip>44651</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Annika Machleit-Ebner</last_name>
      <phone>+49 232349892749</phone>
      <email>a.machleit@evk-herne.de</email>
    </contact>
    <investigator>
      <last_name>Martina Neddermann, Dr. Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 4, 2014</lastchanged_date>
  <firstreceived_date>April 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
